Don't close this page .. Test is protected .. Answers cannot be changed .. We try now to connect to save and correct your answers.
Connection trial number:
If this message persists for long, please check your internet connection.
This test is monitored
Switching to another webpage or any other program is considered a cheating behavior and your test may be automatically terminated.
Okay
Important Notice
If you moved to the next question, you will not be able to come back to this question again.
Cancel
Move to next question
Final exam لمادة صيدلة سريرية ٢ ( الامتحان مشترك)
Student data
×
Student data
Student name: ***
Student number: ***
Class or section: ***
Test instructions
×
Test instructions
التعليمات المهمة بامتحان ١- تاكد من ان عدد الاسءلة هي 141 سؤال ٢- اقرا سؤال جيدا قبل الجواب وعدم تسرع ٣- زمن الامتحان : ساعتان
Page direction
×
Change page direction
Right to left
Left to right
Q1
Score: 0.35
A- NSAID+ PPI
B- NSAID+ prostaglandin analog
C- NSAID+ ASPIRIN
D- NSAID+ full dose histamine H2 blockers daily
Q2
Score: 0.35
صح
خطأ
Q3
Score: 0.35
A- ibuprofen
B- rofecoxib
C- diclofenac
D- all the above
E- non the above
Q4
Score: 0.35
A- Benzbromarone
B- probenecid
C- sulfinpyrazone
D- rasburicase
Q5
Score: 0.35
A- pegloticase is used in severe
B- rasburicase is Uricostatic agent
C- losartan : increase both uric acid excretion and urine oh
D- fenofibrate is also uricosuric and may be appropriate in select dyslipidemia patients with gout
Q6
Score: 0.35
A- monoarticular arthritis
B- just urate level rise in the blood without signs and symptoms
C- most patients have a second attack from 6 months to 2 years
D- complications include soft tissue damage
Q7
Score: 0.35
A- over production of uric acid
B- combined of the above two mechanism
C- under excretion of UA
D- non the above
Q8
Score: 0.35
A- NSAIDS
B- ASPIRIN
C- MONOAMINE - OXIDASE B INHIBITOR
D- WARFARIN
Q9
Score: 0.35
A- target
B- biological
C- conventional
D- non the above
Q10
Score: 0.35
A- is Indirect action dopamine agonists
B- Selegiline is available in an orally disintegrating tablet designed to avoid first pass metabolism
C- Bromocriptine is not commonly used
D- side effect of rasageline are primarily GI related
Q11
Score: 0.35
A- Venlafaxine
B- Trazodone
C- Doxepin
D- Fluoxetine
E- paroxetine
Q12
Score: 0.35
A- because adverse effect includes gastropathy
B- low therapeutic index
C- mucous membranes of the respitory trat
D- non the above
Q13
Score: 0.35
A- probenecid
B- sulfinpyrazone
C- pegloticase
D- febuxostat
Q14
Score: 0.35
صح
خطأ
Q15
Score: 0.35
A- emotional symptoms
B- intellectual or cognitive symptoms
C- physical symptoms
D- non the above
Q16
Score: 0.35
A- class D
B- class B
C- class C
D- class A
Q17
Score: 0.35
صح
خطأ
Q18
Score: 0.35
صح
خطأ
Q19
Score: 0.35
A- is the central hub for sights and sounds
B- is the emotional core of the brain whose primary role is to trigger the fear response
C- to be conscious of what you are seeing and hearing
D- is you memory centere
Q20
Score: 0.35
A- SSRI
B- SNRI
C- TCA
D- FLX
Q21
Score: 0.35
A- 5HT1A IS ANTAGONIST
B- vomiting is 5HT3
C- SARA HAS DRINK ALCOHOL HAS MEAN RISK OF SUICIDE
D- ALL THE ABOVE
Q22
Score: 0.35
A- milder
B- acute
C- more chronic
D- A+ B
E- A+ C
F- all the above
Q23
Score: 0.35
A- advanced age
B- gender
C- all the above
D- non the above
Q24
Score: 0.35
A- anxiety
B- depression
C- eye
D- otitis media
Q25
Score: 0.35
صح
خطأ
Q26
Score: 0.35
A- skin
B- heart
C- all the above
Q27
Score: 0.35
A- first 3 hours
B- first 12 hours
C- first 24 hours
D- first 50 hours
Q28
Score: 0.35
صح
خطأ
Q29
Score: 0.35
A- is the second line
B- all benzodiazepine are equally effective anxiolytics.
C- is the first line
D- effect on GABA
Q30
Score: 0.35
A- given orally vit c
B- orally + SC
C- IV
Q31
Score: 0.35
صح
خطأ
Q32
Score: 0.35
A- 3: 1
B- 2:3
c- 4: 1
D- 2:1
Q33
Score: 0.35
A- patients should be reminded that the optimal effect of antidepressant May not be evident for 4 to 6 weeks
B- Theoretical advantage of SSRIs : require more dosage titration than older agents
C- in practice many clinicians persist in rapidly higher doses over the first few weeks
D- all the above
Q34
Score: 0.35
A- anti acid decrease effect
B- protein decrease effect
C- increase beta 2 breakdowns of levadopa so decrease effect
D- all the above
Q35
Score: 0.35
صح
خطأ
Q36
Score: 0.35
صح
خطأ
Q37
Score: 0.35
صح
خطأ
Q38
Score: 0.35
A- sulphasalazine
B- leflunomide
C- methotrexate
D- hydroxy chloroquine
Q39
Score: 0.35
A- IBS
B- IPD
C- MPTP
D- PARK1
Q40
Score: 0.35
A- is recommended for patient with treatment resistant depression
B- is well tolerated , with minor visual complaints being the most frequently reported event
C- a non - invasive procedure to help fight depression
D- stimulation through a flexible
Q41
Score: 0.35
A- fluxetine
B- hypothyroidsem
C- paroxetine
D- vanflaxine
Q42
Score: 0.35
صح
خطأ
Q43
Score: 0.35
A- vasodilution
B- vasoconstriction
Q44
Score: 0.35
A- dosing of Infliximab is given by IV infusions
B- Etanercept is should be laboratory monitoring is required
C- MOA of Adlimumab is a chimeric antibody combining portions of mouse
D- certolizumab is FDA approved for use in JIA
Q45
Score: 0.35
A- most HA are injected once weekly for either 3 or 5 weeks
B- dose of Glucosamine sulfate: 10 mg
C- works of chondroitin are blocking the enzymes that break down old cartilage
D- Glucosamine and chondroitin are the most common
Q46
Score: 0.35
A- high rate of diarrhea
B- prolong QT interval so consider other medication
C- helps sleep
D- longer half life compared to rest of SSRI
Q47
Score: 0.35
A- fluoxetine
B- sertraline
C- citalopram
D- all the above
Q48
Score: 0.35
A- uses age of onset : 35- 50 years
B- joint pattern is symmetric
C- ESR is normal
D- speed of onset is rapid
Q49
Score: 0.35
صح
خطأ
Q50
Score: 0.35
صح
خطأ
Q51
Score: 0.35
A- TCA
B- SNRI
C- SSRI
D- MOA
Q52
Score: 0.35
A- tremor
B- Dyskinasea
C- bradykinesia
D- postural instability
Q53
Score: 0.35
A- hip
B- pruritus
C- phototoxicity
D- dermatitis
Q54
Score: 0.35
A- pulmonary TB
B- TB menengitise
C- extra pulmonary
Q55
Score: 0.35
A- suicide
B- ECT
C- VNS
D- TMS
Q56
Score: 0.35
صح
خطأ
Q57
Score: 0.35
A- definitive diagnosis
B- is diagnosis of joint fluid may also have an elevated WBC count with neutrophils predominating
C- the diagnosis of acute gouty arthritis may be made on the basis of presence of signs and symptoms
D- non the above
Q58
Score: 0.35
A- steroid
B- high protein intake
C- hyperthyroidism
D- all the above
E- non the above
Q59
Score: 0.35
A- dry mouth
B- sedation
C- constipation.
D- all the above
E- non the above
Q60
Score: 0.35
A- panic disorder
B- generalized anxiety disorder
C- specific phobia
D- Posttraumatic stress disorder
Q61
Score: 0.35
A- specific
B- non specific
C- both
Q62
Score: 0.35
صح
خطأ
Q63
Score: 0.35
A- dry mouth is symptoms of PD
B- PET scan are used to visualize dopamine uptake in the substantia nigra and basal ganglia
C- the goal in the management of IPD is to improve motor and non motor symptoms
D- lifestyle modification is treatment of non pharmacologic therapy by PD
Q64
Score: 0.35
A- 30- 50%
B- 70- 90%
C- 10- 15%
D- 60- 80%
Q65
Score: 0.35
A- microfractures
B- the earliest stage of OA
C- subchondral bone
D- progressive loss of joint space
Q66
Score: 0.35
صح
خطأ
Q67
Score: 0.35
A- the objective in treat OA is reduce pain
B- pharmacologic therapy is integral to achieving optimal outcomes
C- OA is primarily diagnosed on the clinical presentation
D- OA prevalence increased with age
Q68
Score: 0.35
A- 5HT2C
B- 5HT3
C- 5HT1A
D- 5HT2A
E- 5HT2C
F- all the above
Q69
Score: 0.35
A- dose of methotrexate : 5 mg
B- is have no monitoring
C- it is symptomatic relief of choice in RA
D- side effect of methotrexate is dry mouth
Q70
Score: 0.35
A- The class of RA of NSAIDS is disease modifying therapy
B- aspirin is the prototype of traditional NSAIDS
C- corticosteroids they have bad anti- inflammatory
D- methotrexate is used symptomatic relief
Q71
Score: 0.35
A- methotrexate is a JAK inhibitors for use in patients with moderate to severe RA
B- adverse effects of JAK inhibitors they are similar to other biologic agents
C- is the targeted synthetic DMARDs
D- results in modulation and suppression of the immune system through cytokines signal reduction
Q72
Score: 0.35
A- phenelzine
B- Amitriptyline
C- citalopram
D- sertraline
E- Duloxetine
Q73
Score: 0.35
A- on regular diet
B- normal individual
C- over producers
D- under excretors of uric acid
Q74
Score: 0.35
A- selective
B- non selective
C- all the above
Q75
Score: 0.35
A- the crystal shape of gout: rhomboidal
B- joint involve of gout: large
C- pyrophosphate arthropathy also known as calcium pyrophosphate deposition disease
D- prevalence of gout is 0.4%, mf = 3.2 : 60- 80 year of age
Q76
Score: 0.35
A- colchine
B- corticosteroids
C- naproxen
D- ALL THE ABOVE
Q77
Score: 0.35
A- CNC
B- vomiting
C- hyperglycemia
D- fluid retention
Q78
Score: 0.35
صح
خطأ
Q79
Score: 0.35
A- T- cell
B- B- cell
C- IL-6
D- IL-1
E- JAK inhibitor
Q80
Score: 0.35
A- meditation
B- psychotherapy
C- short term counseling
D- exercise
E- psycho- education
Q81
Score: 0.35
A- GABA
B- 5- HT2a
C- 4 - HT
D- b- blocker
Q82
Score: 0.35
A- for 6- 9 month
B- never add single new drug to therapy
C- give drug not intermittent
Q83
Score: 0.35
A- Mirtazapine
B- Fluoxetine
C- paroxetine
D- Amitriptyline
E- vortioxetine
Q84
Score: 0.35
A- Allopurinol and febuxostat are decrease serum uric acid
B- is increase uric acid excretion
C- is included drug : sulfinpyrazone
D- most patient with symptomatic hyperuricemia
Q85
Score: 0.35
A- the life time prevalence of anxiety disorder among American adult is 50%
B- SAD is the most common anxiety disorder
C- the female - to male ratio for any life time anxiety disorder is 1:2
D- all the above
Q86
Score: 0.35
A- SAD can present in children of preschool to elementary school age
B- beta blocker : for not specific SAD only
C- TCA are not effective in SAD
D- beta blocker : a test dose at home
Q87
Score: 0.35
A- gender
B- bony remodeling
C- obesity
D- PIP
Q88
Score: 0.35
A- FLX
B- SNRI
C- TCA
D- SSRI
Q89
Score: 0.35
A- inhibitory properties at serotonin / norepinephrine reuptake transport
B- has potent antihistaminergic effect
C- antagonist at presynaptically a2- auto receptors and heteroreceptor , as well as post synaptic 5 HT2 and 5 HT3 receptor
D- the most common SE s are sedation and weight gain
Q90
Score: 0.35
A- is symptomatic therapy of motor symptoms in early PD
B- side effect is tremor
C- they usually avoided or used with caution in patient > 70 years because of an increase risk of cognitive impairment
D- they decrease gastric motility
Q91
Score: 0.35
A- methotrexate , sulfasalazine , hydroxy chloroquine is triple therapy
B- TNF- alpha is type of symptomatic relief
C- Minocycline is a tetracycline antibiotic
D- gold compound : May be given as IM or Oral
Q92
Score: 0.35
A- zolpidem
B- Diazepam
C- temazepam
D- Fluoxetine
Q93
Score: 0.35
A- second- line therapy
B- is inflammation with OA
C- cox2 inhibitors selectively block cox- 1 and not cox-2 activity
D- non the above
Q94
Score: 0.35
A- Levodopa
B- agents of interest are creatine and isradipine
B- dopamine agonist
D- all the above
Q95
Score: 0.35
A- is functional impairment
B- is remission , patient should be free of panic attacks
C- is minimal agoraphobic avoidance
D- all the above
Q96
Score: 0.35
صح
خطأ
Q97
Score: 0.35
A- SSRIs
B- TCA
C- SNRI
D- SS
Q98
Score: 0.35
صح
خطأ
Q99
Score: 0.35
A- 12
B- 8
C- 10
D- 20
E- 25
Q100
Score: 0.35
A- EST
B- myths
C- light therapy
D- exercise
Q101
Score: 0.35
صح
خطأ
Q102
Score: 0.35
A- sertraline
B- paroxetine
C- citalopram
D- Doxepin
Q103
Score: 0.35
A- selective
B- non selective
C- all the above
Q104
Score: 0.35
A- Bupropion
B- Venlafaxine
C- Aspirin
D- flecainide
Q105
Score: 0.35
A- maintain joint function
B- response to colchicine treatment may suggest t tthe diagnosis
C- achieve rapid
D- avoid treatment related adverse effects
Q106
Score: 0.35
A- the most biologic DMARDs
B- they block TNF, which is a cytokine involved in the infkammato process
C- all TNF alpha inhibitors they are different Indication
D- Adalimumab is treat of Anti- TNF drug
Q107
Score: 0.35
A- APhA
B- GAD
C- PD
D- SAD
Q108
Score: 0.35
A- is metabolized by mono amine oxidase
B- an inert neutral amino acid with no known pharmacologic effect
C- including L- dopa
D- adverse effect is seizure
Q109
Score: 0.35
A- is SNRIs
B- less D- D interaction than with SSRIs
C- is NDRI
D- the most common SEs are sedation and weight gain
Q110
Score: 0.35
A- patient age
B- cost
C- patient preference
D- all the above
Q111
Score: 0.35
A- muscle tone
B- tests
C- maintaining posture
D- regulating voluntary smooth motor activity
Q112
Score: 0.35
A- Naproxen+ PPI
B- can't NSAID
C- Increase NSAIDS
D- avoid NSAIDS if possible
Q113
Score: 0.35
A- adding lithium
B- adding folate
C- adding omega - 3 fatty acids
D- adding an anticonvulsant
Q114
Score: 0.35
A- ethanol
B- loop diuretics
C- cytotoxic drugs
D- nicotinic acid
Q115
Score: 0.35
A- diet
B- degradation of nucleic acid
C- purine base
D- non the above
E- all the above
Q116
Score: 0.35
A- radiographic changes
B- laboratory tests
C- signs
Q117
Score: 0.35
A- delusions
B- weight gain
C- weight loss
D- hallucination
Q118
Score: 0.35
A- infection
B- lipid levels
C- all the above
D- non the above
Q119
Score: 0.35
صح
خطأ
Q120
Score: 0.35
A- Acetaminophen should be administered initially on an as needed basis in daily doses up to 4 g
B- by single dose should exceed 1g
C- Acetaminophen should be tried initially at an adequate dose
D- Acetaminophen is effective for same indications as intermediate dose aspirin
Q121
Score: 0.35
A- phenelzine
B- paroxetine
C- Amitriptyline
D- clomipramine
Q122
Score: 0.35
A- IV
B- Inhaler
C- SC
D- all the above
Q123
Score: 0.35
A- congenital or development deformities
B- erratic new bone formaion
C- bony remodeling
D- development of osteophytes
Q124
Score: 0.35
A- anti depression
B- herbals
C- anti convulsants
D- antibiotics
Q125
Score: 0.35
A- suffient fiber and protein
B- alpha - Tocopherol , Q10 - CO - enzyme
C- Vit E , C
D- all the above
Q126
Score: 0.35
A- panic disorder
B- social phobia
C- specific phobia
D- generalized anxiety disorder
Q127
Score: 0.35
صح
خطأ
Q128
Score: 0.35
A- heart
B- liver
C- joint
D- kidney
Q129
Score: 0.35
A- fewer side- effect
B- safety in over dose
C- high dosage titration
D- A+ B
E- B+ C
F- all the above
G- non the above
Q130
Score: 0.35
A- immediately
B- in addition
C- all the above
D- non the above
Q131
Score: 0.35
A- SNRI and TCA
B- SSRIs and MAOIS
C- CYP and HMG reductases
D- non the above
Q132
Score: 0.35
A- most DMARDS require some form of monitoring to ensure safe therapy
B- NSAIDS and Glucocorticoid is drug of choose by DMARDS
C- DMARDS have slow onset of action
D- they have a major role in managing of RA
Q133
Score: 0.35
صح
خطأ
Q134
Score: 0.35
A- renal damage
B- renal calculi
C- clusters of urate generally surrounded by inflamed tissue
D- non the above
Q135
Score: 0.35
A- selective
B- non selective
C- both
Q136
Score: 0.35
صح
خطأ
Q137
Score: 0.35
A- 29C
B- 33C
C- 21C
D- 37C
Q138
Score: 0.35
A- alkalinization of urine : urine PH should be maintained at 6- 6.5
B- Losartan: DM given 100 mg / dl can be uricosuric
C- Febuxostat: it is a potential alternative to allpurinol for patients with gout
D- celecoxib is COX- 2 selective inhibitor
Q139
Score: 0.35
A- 100 mg
B- 300 mg
C- 500 mg
D- 200 mg
Q140
Score: 0.35
A- male gender
B- obesity
C- metabolic syndrome
D- temperature
Q141
Score: 0.35
A- Mirtazapine
B- lithium
C- aspirin
D- A typical drug
Questions you haven't answered yet:
Are you sure you want to end this test and send your answers?
All copy rights reserved
©
arab-exams.com
2014-2023
Dismiss this alert